M1 Kliniken AG

  • WKN: A0STSQ
  • ISIN: DE000A0STSQ8
  • Land: Deutschland

Nachricht vom 29.08.2016 | 10:12

M1 Kliniken AG - H1 2016: Preliminary IFRS results, sales EUR 18.5 million, operating result (EBIT) EUR 3.0 million; investments in the expansion of hospital capacities and outpatient services

DGAP-News: M1 Kliniken AG / Key word(s): Half Year Results/Dividend

2016-08-29 / 10:12
The issuer is solely responsible for the content of this announcement.


Corporate News of M1 Kliniken AG:
H1 2016: Preliminary IFRS results, sales EUR 18.5 million, operating result (EBIT) EUR 3.0 million; investments in the expansion of hospital capacities and outpatient services

In the first half-year 2016 M1 Kliniken AG, Berlin (ISIN: DEA0STSQ8), achieved IFRS Group sales of EUR 18.5 million (previous year total: EUR 34.9 million) and an operating result (EBIT) of EUR 3.0 million (previous year total: EUR 7.0 million).

"The clinic in Berlin received on April 14th 2016 the concession for the enlargement to six operating rooms and 34 patient beds. In Germany we are now active with twelve M1-outpatient service centres. The expansion of capacities will allow M1 further growth in the course of the year 2016", says Patrick Brenske, Member of the Management Board of M1 Kliniken AG.

About M1 Klinken AG:

M1 Kliniken AG is one of the leading private providers of health care services in the medical beauty market. M1 group offers products and services "Made in Germany" to customers throughout Germany with a broad spectrum of aesthetic and surgical treatments.
Experienced and highly specialised teams of medical specialists use high-class products and state-of-the-art medical technology for minimally invasive surgery and plastic surgery on highest quality standards.

M1 Kliniken AG is listed in the Entry Standard (Open Market) on the Frankfurt Stock Exchange.
Key figures for the share of M1 Kliniken AG:
Subscribed capital: EUR 15,000,000
Listed shares: bearer shares
ISIN: DE000A0STSQ8
WKN: A0STSQ
Stock symbol: M12

Contact:
M1 Kliniken AG
Grünauer Straße 5
D-12557 Berlin
Phone: +49 (0)30 887 086 225
Fax: +49 (0)30 887 086 228
E-Mail: ir@m1-kliniken.de Web: www.m1-kliniken.ag



2016-08-29 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


show this

GBC-Fokusbox

UniDevice AG: Fortsetzung des Wachstumskurses erwartet

Im ersten Halbjahr 2020 verzeichnete die UniDevice AG ein deutliches Umsatz- (+5,9 %) und überproportionales EBIT-Wachstum (+38,6 %). Der Broker für Kommunikations- und Unterhaltungselektronik mit Schwerpunkt auf hochpreisige Smartphones erwartet für das Gesamtjahr die Fortsetzung des eingeschlagenen Wachstumskurses und weiterhin eine spürbare Verbesserung des Rentabilitätsniveaus. Bei einem von uns ermittelten Kursziel von 3,85 € vergeben wir das Rating KAUFEN.

News im Fokus

Delivery Hero verstärkt seine globale Präsenz und erwirbt Glovos Geschäft in Lateinamerika

16. September 2020, 17:45

Aktuelle Research-Studie

Coreo AG

Original-Research: Coreo AG (von GBC AG): Kaufen

18. September 2020